Rationale and Design of the EMPYREAN StudyHirohiko Motoki, Koichiro Kuwahara, Masako Waki et al.|ESC Heart Failure|2020Cited by 7
Investigation of the Effect of Empagliflozin on Cardiac Sympathetic and Parasympathetic Nerve Activity Analyzed From Heart Rate Variability Frequency in Japanese Patients With Type 2 Diabetes ― Results From the EMPYREAN Study ―Hirohiko Motoki, Izuru Masuda, Koji Oba et al.|Circulation Journal|2025Cited by 3
Prognostic Impact of Cardio-renal-anemia Syndrome in Patients at Risk for Heart Failure from the IMPACT-ABI studyWataru Shoin, Koichiro Kuwahara, Hirohiko Motoki et al.|Institutional Repositories DataBase (IRDB)|2020Cited by 0
Rationale and Design of the EMPYREAN Study: Investigation on the Effect of Empagliflozin on Cardiac Sympathetic and Parasympathetic Nerve Activity in Japanese Patients with Type 2 DiabetesHirohiko Motoki, Koichiro Kuwahara, Izuru Masuda et al.|Unknown|2020Cited by 0